South African study finds Pfizer vaccine stops 70% of hospitalizations from omicron
A new study out of South Africa found that Pfizer’s mRNA vaccine offered only 30% protection against infection by the omicron variant, but it did offer 70% protection against severe disease.
Pfizer also released new data showing its COVID-19 pill was effective in preventing hospitalization and death.
Here & Now‘s Scott Tong speaks with Dr. Angela Rasmussen, a virologist at the vaccine and infectious disease organization at the University of Saskatchewan.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org.